GENNEX LABORATORIES LTD.

NSE : NABSE : 531739ISIN CODE : INE509C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE15.800.21 (+1.35 %)
PREV CLOSE ( ) 15.59
OPEN PRICE ( ) 15.11
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 790292
TODAY'S LOW / HIGH ( )15.11 16.80
52 WK LOW / HIGH ( ) 5.3521.89
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax63.7352.7650.6225.4930.27
Adjustment-3.8825.6615.7016.7917.31
Changes In working Capital176.9151.77-65.36-58.95-25.31
Cash Flow after changes in Working Capital236.76130.180.97-16.6722.27
Cash Flow from Operating Activities236.76119.08-14.37-16.7118.76
Cash Flow from Investing Activities-383.29-24.66-0.25-2.15-9.94
Cash Flow from Financing Activities210.33-18.3116.19-3.4712.47
Net Cash Inflow / Outflow63.8176.111.57-22.3421.28
Opening Cash & Cash Equivalents86.8410.729.1331.4710.18
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent150.6486.8410.699.1331.47

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.